Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
When hives flare up unexpectedly, patients often wonder which treatment and procedures will bring fast, lasting relief. Liv Hospital’s dermatology team specializes in urticaria care, offering a full spectrum of evidence‑based options tailored to each individual. Whether you are a traveler seeking rapid symptom control or a long‑term patient managing chronic outbreaks, this guide outlines everything you need to know—from diagnosis to cutting‑edge therapies—so you can make informed decisions before you arrive in Istanbul.
Urticaria affects up to 20 % of the global population at some point in life, and about 1 % develop chronic forms that persist for six weeks or longer. Prompt, accurate treatment and procedures can prevent the condition from disrupting daily activities, work, and travel plans. In the following sections we explore the underlying causes, diagnostic pathways, conventional medications, advanced interventions, lifestyle strategies, and practical tips for international patients preparing for their visit.
Urticaria, commonly known as hives, is a skin reaction characterized by raised, red or skin‑colored welts that itch intensely. Recognizing the type of urticaria you have is the first step toward effective treatment and procedures. The condition is broadly divided into two categories:
Within these categories, several subtypes exist:
Understanding these patterns helps clinicians select the most appropriate treatment and procedures, whether that involves simple antihistamines or more specialized biologic therapies.
A thorough assessment is essential to differentiate between acute and chronic forms and to uncover any hidden triggers. At Liv Hospital, the diagnostic pathway combines clinical evaluation with targeted laboratory testing.
The dermatologist records:
Standard tests include:
If physical urticaria is suspected, provocation tests such as the cold stimulation test or pressure test are performed under controlled conditions.
All findings guide the selection of personalized treatment and procedures, ensuring that therapy addresses the root cause rather than just the symptoms.
First‑line therapy for most urticaria patients relies on antihistamines, which block histamine receptors and reduce wheal formation. Liv Hospital follows the latest international guidelines to optimize medication regimens.
These non‑sedating agents are preferred for daily use:
If symptoms persist after two weeks, the dose may be doubled up to fourfold, a strategy supported by clinical trials.
When antihistamines alone are insufficient, additional agents are introduced:
For chronic spontaneous urticaria unresponsive to high‑dose antihistamines, the monoclonal antibody omalizumab is now considered a standard treatment and procedure. It binds circulating IgE, reducing mast cell activation. Typical dosing is 300 mg subcutaneously every four weeks, with response rates exceeding 80 % in clinical studies.
These conventional options form the backbone of urticaria management and are often sufficient to achieve remission in the majority of patients.
When standard medication fails, Liv Hospital offers a suite of advanced interventions that go beyond conventional treatment and procedures. These options are especially valuable for patients with refractory chronic urticaria or those experiencing severe physical urticaria.
Controlled exposure to ultraviolet light can modulate immune responses in the skin. A typical PUVA regimen involves three times weekly sessions for 8–12 weeks, with careful monitoring for phototoxicity.
Low‑dose cyclosporine (2–4 mg/kg/day) is an immunosuppressant that has shown rapid improvement in severe chronic urticaria. Regular kidney function and blood pressure checks are mandatory during therapy.
New agents targeting interleukin‑5 (IL‑5) and the IL‑31 pathway are under investigation. Early phase trials suggest they may provide relief for patients who do not respond to omalizumab.
These advanced treatment and procedures are administered in Liv Hospital’s state‑of‑the‑art dermatology suite, where a multilingual care team ensures safety, comfort, and clear communication for international patients.
Medication alone rarely eliminates urticaria; identifying and avoiding triggers is a cornerstone of long‑term control. The following lifestyle strategies complement medical treatment and procedures and empower patients to maintain symptom‑free periods.
While food allergies account for a minority of cases, a low‑histamine diet can be beneficial for some patients. Recommended steps include:
Psychological stress is a well‑documented trigger. Techniques such as mindfulness meditation, yoga, and guided breathing have demonstrated reductions in urticaria activity scores.
For physical urticaria, patients should:
Consistent use of prescribed antihistamines, even on asymptomatic days, prevents rebound mast cell activation. Setting daily reminders or using pill organizers can improve compliance.
Integrating these non‑pharmacologic measures with the clinical treatment and procedures offered at Liv Hospital creates a comprehensive, patient‑centered plan that reduces recurrence and improves quality of life.
Liv Hospital is experienced in welcoming patients from around the globe. Understanding the logistical and medical steps before arrival ensures a smooth transition into care.
Gather the following items and forward them securely to the hospital’s International Patient Services team:
Upon receipt of your documents, a dedicated coordinator will:
During your visit, you will benefit from:
After discharge, the International Patient Services team arranges virtual follow‑ups to monitor response to the prescribed treatment and procedures. Prescription refills can be coordinated with local pharmacies or shipped directly from our in‑house pharmacy.
By planning ahead, international patients can focus on recovery and enjoy a stress‑free experience while receiving world‑class urticaria care.
Liv Hospital combines JCI accreditation, cutting‑edge dermatology expertise, and a dedicated international patient program. Our Istanbul campus offers state‑of‑the‑art facilities, multilingual staff, and seamless coordination of appointments, travel, and accommodation. Patients trust us for safe, effective treatment and procedures that adhere to global standards, all delivered in a compassionate, culturally sensitive environment.
Ready to regain control of your skin health? Contact Liv Hospital’s International Patient Services today to schedule your personalized urticaria consultation and start your journey toward lasting relief.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
For most patients with acute or chronic urticaria, non‑sedating second‑generation antihistamines such as cetirizine, fexofenadine, or levocetirizine are prescribed once daily. If symptoms persist after two weeks, the dose can be increased up to fourfold under medical supervision. These drugs block histamine receptors, reducing wheal formation and itching without causing significant drowsiness.
If a patient with chronic spontaneous urticaria fails to achieve control after maximizing antihistamine therapy, the monoclonal antibody omalizumab is recommended. It binds circulating IgE, decreasing mast cell activation. The typical regimen is 300 mg subcutaneously every four weeks, and clinical studies show response rates above 80 % with significant reduction in wheal count and itch intensity.
At Liv Hospital, the diagnostic work‑up begins with a detailed history and physical examination to identify trigger patterns. Laboratory tests include a complete blood count to detect eosinophilia, serum IgE levels, thyroid function tests (as hypothyroidism can be linked to chronic urticaria), and autoimmune panels such as ANA and anti‑thyroid antibodies. For suspected physical urticaria, provocation tests like cold stimulation or pressure testing are performed under controlled conditions.
Medication alone rarely eliminates urticaria. Patients are advised to keep a food diary and limit high‑histamine foods such as aged cheeses, smoked meats, and fermented products. Alcohol, especially red wine, should be reduced. Stress management techniques—mindfulness, yoga, and breathing exercises—have been shown to lower urticaria activity scores. Environmental measures like avoiding extreme temperatures, wearing loose clothing, and using hypoallergenic detergents also help.
When conventional therapy fails, Liv Hospital provides phototherapy (PUVA or narrow‑band UVB) typically three times weekly for 8–12 weeks, monitoring for phototoxicity. Low‑dose cyclosporine (2–4 mg/kg/day) can induce rapid remission in severe cases but requires regular kidney function and blood pressure checks. Emerging biologics that inhibit interleukin‑5 or interleukin‑31 pathways are currently in clinical trials and may become options for patients unresponsive to omalizumab.
International patients should forward recent blood work, allergy test results, a complete medication list with dosages, and a concise medical history focusing on skin and autoimmune conditions. A copy of the passport and visa (if required) is also needed. After receipt, the International Patient Services team schedules a video consultation with a dermatologist, creates a personalized treatment plan, and assists with airport transfers, accommodation, and on‑site interpreter services.
BlogDermatologyDec 29, 2025Did you know that nearly 20% of the population will experience urticaria at some point in their lives? Urti...
BlogDermatologyDec 23, 2025Did you know a simple ice cube test can help diagnose a common condition? Cold urticaria, where cold causes...
BlogDermatologyMar 19, 2026Many of us wonder if warts mean our immune system is weak. Warts are caused by the human papillomavirus (HP...
BlogDermatologyDec 23, 2025Urticaria is a condition that makes your skin itchy and bumpy. It affects millions of people around the wor...
BlogDermatologyDec 23, 2025Urticaria, also known as hives, is a skin issue with itchy, raised welts. It’s a common problem that ...
BlogDermatologyMar 17, 2026Restore your skin health and comfort with Liv Hospital's expert care for soap allergy. Identify triggers an...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17